Hicks Derek
Intellia Therapeutics, Inc. · EVP
Hicks Derek is listed in filings as EVP at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2025, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Jan 7, 2025. Reported amounts are shown as $79.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $79k6.5k shares | SellJan 3, 2025 | $12.18 | $13.04 |